10-K/A

AMENDMENT NO. 1

Company: Xenetic Biosciences, Inc.
Filed: April 30, 2018
Period of Report: December 31, 2017
Accession Number: 0001683168-18-001121

View Document ↗ View on SEC.gov ↗